MedPath

LMD 10% IN DEXTROSE 5%

LMD 10% IN DEXTROSE 5%

Approved
DIN Number

00224235

Drug Class

Human

Market Date

Dec 31, 1968

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00224235
AIG Number0202184001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05AA55 DEXTRAN,COMBINATIONS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

DEXTRANActive
Strength: 10 %
Monograph: DEXTRAN
DEXTROSEActive
Strength: 5 %
Monograph: DEXTROSE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.